Literature DB >> 15334045

Treatment of sleep disordered breathing and obstructive sleep apnea.

G A Stephen1, P S Eichling, S F Quan.   

Abstract

The management of sleep disordered breathing (SDB) and obstructive sleep apnea (OSA) in adults can be challenging. Treatment recommendations are based on a number of factors including the severity of SDB, the existence and extent of comorbid conditions, the severity of presenting symptoms and patient preference. General management includes addressing lifestyle issues, particularly weight loss and the avoidance of sedatives. The primary specific treatment modality for SDB is continuous positive airway pressure (CPAP). However, for selected patients that cannot accept this therapy, other modalities such as upper airway surgery and oral appliances should be considered.

Entities:  

Mesh:

Year:  2004        PMID: 15334045

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  4 in total

1.  Association of physical activity with sleep-disordered breathing.

Authors:  Stuart F Quan; George T O'Connor; Jason S Quan; Susan Redline; Helaine E Resnick; Eyal Shahar; David Siscovick; Duane L Sherrill
Journal:  Sleep Breath       Date:  2007-09       Impact factor: 2.816

Review 2.  Sleep disturbances in patients with post-traumatic stress disorder: epidemiology, impact and approaches to management.

Authors:  Michael J Maher; Simon A Rego; Gregory M Asnis
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 3.  Methods for increasing upper airway muscle tonus in treating obstructive sleep apnea: systematic review.

Authors:  Juliana Spelta Valbuza; Márcio Moysés de Oliveira; Cristiane Fiquene Conti; Lucila Bizari F Prado; Luciane Bizari Coin de Carvalho; Gilmar Fernandes do Prado
Journal:  Sleep Breath       Date:  2010-06-19       Impact factor: 2.816

4.  Quality measures for the care of adult patients with obstructive sleep apnea.

Authors:  R Nisha Aurora; Nancy A Collop; Ofer Jacobowitz; Sherene M Thomas; Stuart F Quan; Amy J Aronsky
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.